AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
1 pistes • 0 écoutes • 0 favoris
AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
Simolabhaj
0:001:35
Entrepreneurship Strategy
Épisodes
1
AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
Simolabhaj